1211P Indirect comparison of mobocertinib and standard of care in platinum-pretreated patients with NSCLC with EGFR exon 20 insertion

Autor:	Duc Minh Nguyen, H. Lin, J-L. Hong, M. Mehta, S. Jin, Y. Yin, Joel W. Neal, Jianchang Lin, S-H.I. Ou
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Standard of care business.industry chemistry.chemical_element Hematology Indirect comparison Exon chemistry Internal medicine medicine Platinum business
Zdroj:	Annals of Oncology. 32:S964-S965
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.1816
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f14c4392cdc380e4670bba0ce0f1bb54 https://doi.org/10.1016/j.annonc.2021.08.1816 Zobrazit plný text záznamu